Ian Judson
Institute of Cancer Research
Royal Marsden Hospital
Fulham Road
Belmont
London
SW3 7JJ
United Kingdom
Tel: 020 8722 4303
Recent publications
Reply: Clinical outcome and prognostic factors for patients treated within a phase I study: the Royal Marsden Hospital Experience
Br J Cancer.2008;99 :1365-1365
An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models
Cancer Chemother Pharmacol.2008;62 :769-778
Increase text
Decrease text
Print this page